Tian Tian

Sobre mi

Publicacions destacades

• Anticancer activity of RAS-GTP inhibition in cholangiocarcinoma.

  Autors:

  Entrialgo-Cadierno R; Morali K; Feliu I; Wang Y; Evans JW;

  (...)

  Tian TV; Aronchik I; Singh M; Jiang J; Vicent S.

  Veure llistat complet d'autors

  Referència: CANCER CELL 2026.

• Perineural invasion is a prognostic factor in cholangiocarcinoma, regardless of anatomical location: A systematic review and meta-analysis

  Autors:

  Conti, Sefora; Tissera, Natalia S; Castet, Florian; Basagana-Farres, Miriam; Salcedo, Maria Teresa;

  (...)

  Turpin, Anthony; Garces, Victor Navarro; Villacampa, Guillermo; Macarulla, Teresa; Tian, Tian, V.

  Veure llistat complet d'autors

  Referència: JHEP Rep 2026.

• Claudin 18.2 expression in gastroesophageal adenocarcinoma: biomarker overlap and association with clinical outcomes in a European cohort

  Autors:

  Teran, E; Pazo, R; Carita, L; Alsina, M; Hierro, C;

  (...)

  Vivancos, A; Tabernero, J; Elez, E; Tian, T, V; Macarulla, T.

  Veure llistat complet d'autors

  Referència: ESMO Open 2026.

• Evolving treatment strategies for resectable gastric cancer: Bridging Asia-West disparities toward personalized and integrated therapy☆

  Autors:

  Zhao, Xuesong; Hao, Qianyun; Alsina, Maria; Acosta, Daniel; Castet, Florian;

  (...)

  Shoji, Hirokazu; Lordick, Florian; Shen, Zhanlong; Tian, Tian, V; Macarulla, Teresa.

  Veure llistat complet d'autors

  Referència: CANCER TREATMENT REVIEWS 2025.

• Comparative genomic landscape of acquired resistance in pancreatic cancer treated with pan-RAS or KRASG12C inhibitors.

  Autors:

  Castet F; Tian TV; Macarulla T;

  Referència: ANNALS OF ONCOLOGY 2025.

• From obscurity to opportunity: targeting Neuregulin 1 fusions in solid tumors.

  Autors:

  Llorente S; Lamarca A; Tian TV;

  Referència: Signal Transduct Target Ther 2025.

• Stromal barriers to the abscopal effect

  Autors:

  Tian, Tian, V; Affo, Silvia;

  Referència: CANCER CELL 2025.

• Clinical Value of Liquid Biopsy in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma During Targeted Therapy

  Autors:

  Gonzalez-Medina, Alberto; Vila-Casadesus, Maria; Gomez-Rey, Marina; Fabregat-Franco, Carles; Sierra, Alexandre;

  (...)

  Miquel, Josep M; Nuciforo, Paolo; Perez-Lopez, Raquel; Macarulla, Teresa; Vivancos, Ana.

  Veure llistat complet d'autors

  Referència: CLINICAL CANCER RESEARCH 2024.

• SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinoma

  Autors:

  Luk IS; Bridgwater CM; Yu A; Boila LD; Yáñez-Bartolomé M;

  (...)

  Yeung RS; Tian TV; Haas W; Saha SK; Kugel S.

  Veure llistat complet d'autors

  Referència: Science Translational Medicine 2024.

• Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation

  Autors:

  Serra-Camprubi, Queralt; Verdaguer, Helena; Oliveros, Winona; Lupion-Garcia, Nuria; Llop-Guevara, Alba;

  (...)

  Arribas, Joaquim; Tabernero, Josep; Peiro, Sandra; Macarulla, Teresa; Tian, Tian, V.

  Veure llistat complet d'autors

  Referència: CLINICAL CANCER RESEARCH 2023.

Projectes destacats

• Patient-derived models for the research and evaluation of discovery and innovation in combination therapies for biliary tract cancer (PREDICT-BC)

  Investigador/a principal: Tian Tian Tao

  Finançador: EU TRANSCAN-3 JTC2024

  Durada: 01/10/2025 - 30/09/2028

• Desarrollo de nuevas estrategias para mejorar las terapias dirigidas del colangiocarcinoma

  Investigador/a principal: Tian Tian Tao

  Finançador: Ministerio de Ciencia, Innovación y Universidades

  Codi: PID2023_146827OB-I00

  Durada: 01/01/2025 - 31/12/2027

• Hacia una terapia de receptores de antígenos quiméricos de próxima generación para el colangiocarcinoma (TARQ-CCA)

  Finançador: Fundació AstraZeneca

  Durada: 01/11/2024 - 31/12/2026

• Deciphering epigenetic features hidden in the plasma of cholangiocarcinoma patients

  Investigador/a principal: Tian Tian Tao

  Finançador: FERO Foundation XXII edition Prize

  Durada: 01/01/2023 - 31/12/2024

• Targeting chromatin-associated proteins in cancers

  Investigador/a principal: Tian Tian Tao

  Finançador: Ministerio de Ciencia, Innovación y Universidades

  Codi: RYC2020-029098-I

  Durada: 01/05/2022 - 30/04/2027